BSEInsider Trading / SAST30 Sept 2026 · 30 Sept 2026, 08:13 pm
CLOSURE OF TRADING WINDOW
Beryl Drugs Ltd · 524606
✦ AI SummaryMgmt Change
Beryl Drugs Ltd has announced the closure of its trading window for all board members, promoters, and connected persons from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Beryl Drugs Ltd - 524606 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
878f1bf5-3b7b-495d-895b-7e4cc02e1593.pdf
View document text
BEFEHL
DRUGS LIMITED
Regd. Off.: 29, Neer Nagar, "Mayank Water Park Road", Bicholi Hapsi, INDORE-452016 (M.P.) INDIA
Tel. e: (0731) 2517677 | E-mai Al : beryldrugs25@y ahoo. ecom | CIN : L024 23MP1993PLC007840
Date: 30*" September, 2026
The Secretary,
The Bombay Stock Exchange Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai — 400 001
Sub.: NOTICE FOR CLOSURE TRADING WINDOW IN THE SHARES OF THE COMPANY FOR THE QUARTER
ENDED 30" SEPTEMBER, 2026
Scrip Code: 524606
ISIN- INE415H01017
Dear Sir/ Madam,
With reference to the BSE circular no LIST/COMP/01/2019-20 dated 2" April, 2019 and in terms of the
Code of Conduct adopted by the Company to regulate, monitor and report trading by insiders read with
to SEBI (Prohibition of Insider Trading) Regulations, 2015, we hereby submit that the, trading window
for dealing in Securities of the Company would remain closed for all the Board Members, Promoters,
Designated/ Specified connected persons of the Company from 1 October, 2026 till 48 hours after
declaration of the Unaudited Financial Results of the Company for the Quarter ended 30 September,
2026, the date of the Board Meeting for declaration of Unaudited Financial Results of the Company for
the Quarter ended on 30" September, 2026 will be intimated in due course.
This is for your information and record.
For Beryl DrugLsi nid\
/\/J G
Sudhir Seth‘ f et
Chairman& \\
DIN: 0009017 B